Sameet Chavan of Angel One, recently shared his insights and recommendations with CNBC-TV18.

Share Market Live

NSE

Chavan's first pick was ICICI Bank. He expressed his optimism about the bank's prospects at its current levels, citing recent developments in the stock. Despite some consolidation in the past, ICICI Bank showed signs of life with notable traction.

Chavan anticipated a substantial move upward for ICICI Bank, possibly even catching up with its peer, Axis Bank, which was trading at an all-time high. This bullish outlook led him to recommend buying ICICI Bank, setting a stop loss at Rs 978 and targeting Rs 1,015. This strategy reflects his belief in the potential for significant gains in the near future.

It's worth noting that ICICI Bank had already demonstrated its strength by gaining more than 3 percent over the past month.

While the banking sector had its appeal, Chavan also turned his attention to the pharmaceutical industry, which had been experiencing buoyancy. Among the pharmaceutical stocks, Glenmark Pharma particularly caught his eye. This company had not only surpassed its recent high but was also trading at a multi-year high.

What intrigued Chavan the most was the intensity exhibited by Glenmark Pharma in terms of both price and volume breakout. He saw this as a strong indicator of a continued uptrend, with a potential move towards Rs 890 in the coming days. As a momentum trader, Chavan advised going long on Glenmark Pharma but cautioned investors to set a stop loss at Rs 844 to manage risks effectively.

Glenmark Pharma had already made impressive gains, surging by more than 7 percent in the past month, showcasing its robust growth potential in the pharmaceutical sector.

Disclaimer:

The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.